These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26111647)
41. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models. Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002 [TBL] [Abstract][Full Text] [Related]
42. A novel mechanism for the pyruvate protection against zinc-induced cytotoxicity: mediation by the chelating effect of citrate and isocitrate. Sul JW; Kim TY; Yoo HJ; Kim J; Suh YA; Hwang JJ; Koh JY Arch Pharm Res; 2016 Aug; 39(8):1151-9. PubMed ID: 27515054 [TBL] [Abstract][Full Text] [Related]
43. Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons. Cho KS; Lee EJ; Kwon KJ; Gonzales EL; Kim YB; Cheong JH; Bahn GH; Lee J; Han SH; Kim YT; Shin CY Food Funct; 2014 May; 5(5):951-60. PubMed ID: 24599349 [TBL] [Abstract][Full Text] [Related]
44. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model. Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992 [TBL] [Abstract][Full Text] [Related]
46. Cilostazol restores autophagy flux in bafilomycin A1-treated, cultured cortical astrocytes through lysosomal reacidification: roles of PKA, zinc and metallothionein 3. Kim HN; Seo BR; Kim H; Koh JY Sci Rep; 2020 Jun; 10(1):9175. PubMed ID: 32514052 [TBL] [Abstract][Full Text] [Related]
47. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258 [TBL] [Abstract][Full Text] [Related]
48. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator. Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066 [TBL] [Abstract][Full Text] [Related]
49. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells. Sanada F; Kanbara Y; Taniyama Y; Otsu R; Carracedo M; Ikeda-Iwabu Y; Muratsu J; Sugimoto K; Yamamoto K; Rakugi H; Morishita R Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):545-52. PubMed ID: 26769045 [TBL] [Abstract][Full Text] [Related]
50. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse. Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804 [TBL] [Abstract][Full Text] [Related]
51. Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes. Chang I; Cho N; Koh JY; Lee MS Diabetologia; 2003 Sep; 46(9):1220-7. PubMed ID: 12898018 [TBL] [Abstract][Full Text] [Related]
52. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076 [TBL] [Abstract][Full Text] [Related]
54. Cytokine-induced expression of tPA is differentially modulated by NO and ROS in rat mesangial cells. Eberhardt W; Beck KF; Pfeilschifter J Kidney Int; 2002 Jan; 61(1):20-30. PubMed ID: 11786081 [TBL] [Abstract][Full Text] [Related]
55. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats. Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935 [TBL] [Abstract][Full Text] [Related]
56. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model. Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606 [TBL] [Abstract][Full Text] [Related]
57. Cilostazol but not sildenafil prevents memory impairment after chronic cerebral hypoperfusion in middle-aged rats. Godinho J; de Oliveira JN; Ferreira ED; Zaghi GG; Bacarin CC; de Oliveira RM; Milani H Behav Brain Res; 2015 Apr; 283():61-8. PubMed ID: 25623419 [TBL] [Abstract][Full Text] [Related]
58. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation. Kim MJ; Lee JH; Park SY; Hong KW; Kim CD; Kim KY; Lee WS Pharmacol Res; 2006 Oct; 54(4):261-7. PubMed ID: 16822680 [TBL] [Abstract][Full Text] [Related]
59. Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. Sheline CT; Behrens MM; Choi DW J Neurosci; 2000 May; 20(9):3139-46. PubMed ID: 10777777 [TBL] [Abstract][Full Text] [Related]
60. Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis. Ke K; Safder AM; Sul OJ; Suh JH; Joe Y; Chung HT; Choi HS PLoS One; 2015; 10(5):e0124869. PubMed ID: 25992691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]